Biotechnology Stocks II Performance Guide: Sage Therapeutics, Inc. (SAGE)
SAGE has no dividends.
Table and Chart of SAGE Performance
See what a $1,000 investment in SAGE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SAGE Returns | |
|---|---|
| Start Date | Aug-29-2014 |
| Start Price | $28.92 |
| End Date | May-16-2024 |
| End Price | $12.01 |
| # Prices | 118 |
| Min Date | May-16-2024 |
| Min Price | $12.01 |
| Max Date | Jan-31-2018 |
| Max Price | $189.80 |
| Total Return | -58.47% |
| Annualized Return | -8.55% |
| Current Value of $1,000 Purchase | $415 |
| Number Returns | 6,903 |
| Average Return | 14.86% |
| Number Profitable Returns | 2,793 |
| Percent Profitable Returns | 40.46% |
| Number Unprofitable Returns | 4,110 |
| Percent Unprofitable Returns | 59.54% |
| Profitable to Unprofitable Returns Ratio | 0.68 |
| SAGE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $704,731,000 |
| Beta | 0.907 | Price to Sales | 10.73 |
| Earnings per Share | $-8.3900 |
| PE Ratio | None |
| PE to Growth Ratio | 0.74 |
| Price to Book | 1.162 |
| PRICE DATA | |
| 52 Week High | $59.99 |
| 52 Week Low | $10.92 |
| Analyst Target Price | $21.88 |
| 50-Day Moving Average | $16.2 |
| 200-Day Moving Average | $20.33 |
| FINANCIAL DATA | |
| Revenue per Share | $1.519 |
| Revenue | $91,063,000 |
| Profit Margin | 0% |
| Return on Equity | -54.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SAGE Compare Returns with S&P 500
SAGE Trendline Chart
SAGE Moving Average Chart
SAGE Stock Return Map - See Patterns of Gains and Losses
SAGE Stock Returns/Purchase Dates